38I Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Intellia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 14.78 EUR -1.2% Market Closed

Market Cap: €1.4B

I	Intellia Therapeutics Inc F:38I	US
S	SSE PLC DUS:SCT	UK
	HAL Trust AEX:HAL	MC
A	Amrize AG F:J0J	US

Profitability Summary

Intellia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-652%

Negative 3Y Average Operating Margin

-997%

Operating Margin is Increasing

-867% > -652%

Negative Net Margin

-610%

Negative 3Y Average Net Margin

-948%

Net Margin is Increasing

-855% > -610%

Negative Free Cash Flow Margin

-585%

Negative 3Y Average Free Cash Flow Margin

-686%

Free Cash Flow Margin is Increasing

-725% > -585%

Negative ROE

-53%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-144%

ROIC is Increasing

-146% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.